Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BPaL(M) Regimen for MDR/RR-TB in Korea
NCT05381194Phase 4Recruiting
- Sponsor
- Asan Medical Center
- Start
- Dec 2022
- Primary completion
- Dec 2027
- Modality
- Prodrugs/Conditional Activator Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bedaquiline, pretomanid, linezolid, moxifloxacin in Tuberculosis (TB), sponsored by Asan Medical Center. Started Dec 2022; status: recruiting.
02
Drugs
bedaquilinepretomanidlinezolidmoxifloxacin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT05381194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05381194.